First isoniazid/rifapentine generic prequalified
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
WHO and FAO are pleased to announce the publication of the second edition of the Manual on development and use of FAO and WHO specifications for chemical pesticides.
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Recently, seven active ingredient Technical Material (TC) products, previously evaluated by WHO, were withdrawn by the recognized applicants. In so doing, the appli
WHO PQT/VCP recently published the following report - Product Review Report - Insecticide Treated Nets Formulated with Pyrethroid+PBO and Pyrethroid+2nd Ac
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
New Invitation for Expression of Interest (EOI) for Active Pharmaceutical Ingredients (APIs) published
A) The followin
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Two PQT Medicines (virtual) trainings for regulators will take palce during June 2022.
WHO Prequalification Unit (PQT) added the below new products to its prequalified list:
The World Health Organization (WHO) is today confirming the suspension of supply of Covaxin produced by Bharat, through UN procurement agencies and recommending to countries that received the vacci
Emergency Use Listing (EUL) for candidate in vitro diagnostics (IVDs) to detect SARS-CoV-2 remains ongoing.
Remdesivir invited for COVID-19:
New Invitation for Expression of Interest (EOI) for Active Pharmaceutical Ingredients (APIs) published
Addition under section:
WHO Prequalification Unit (PQT) added the below new products to its prequalified list: